Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 10 | $31,057,203 |
Sells | 234 | $215,215,543 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Mar 2024 | Sale | 1,776 | 25.71 | 45,661 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Mar 2024 | Sale | 17,825 | 25.48 | 454,181 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 08 Mar 2024 | Sale | 689 | 27.31 | 18,817 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 08 Mar 2024 | Sale | 54,648 | 26.72 | 1,460,195 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 08 Mar 2024 | Sale | 34,663 | 25.46 | 882,520 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 11 Mar 2024 | Sale | 2,292 | 25.7 | 58,904 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 08 Mar 2024 | Sale | 291 | 27.41 | 7,976 | D |
13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 08 Mar 2024 | Sale | 26,908 | 26.66 | 717,367 | D |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 11 Mar 2024 | Sale | 8,618 | 25.93 | 223,465 | D |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 11 Mar 2024 | Sale | 7,769 | 26.12 | 202,926 | D |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 11 Mar 2024 | Sale | 9,928 | 26.1 | 259,121 | D |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 11 Mar 2024 | Sale | 40,072 | 25.42 | 1,018,630 | D |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 08 Mar 2024 | Sale | 160,670 | 26.72 | 4,293,102 | D |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 08 Mar 2024 | Sale | 435 | 27.38 | 11,910 | D |
12 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 08 Mar 2024 | Sale | 202,238 | 25.3 | 5,116,621 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 11 Mar 2024 | Sale | 1,590 | 24.99 | 39,734 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 11 Mar 2024 | Sale | 1,082 | 25.7 | 27,807 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 08 Mar 2024 | Sale | 289 | 27.33 | 7,898 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 08 Mar 2024 | Sale | 30,755 | 25.31 | 778,409 | D |
12 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 08 Mar 2024 | Sale | 55,208 | 26.72 | 1,475,158 | D |
12 Mar 2024 21:58 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 12 Mar 2024 | Sale | 1,030 | 25.58 | 26,347 | D |
12 Mar 2024 21:58 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 11 Mar 2024 | Sale | 1,585 | 25.7 | 40,734 | D |
12 Mar 2024 21:42 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Mar 2024 | Sale | 2,081 | 25.7 | 53,482 | D |
11 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | HIGH SUSANNA GATTI | Chief Operating Officer | 07 Mar 2024 | Sale | 1,591 | 25.85 | 41,127 | D |
11 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 07 Mar 2024 | Sale | 2,373 | 25.85 | 61,342 | D |
11 Mar 2024 21:57 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 07 Mar 2024 | Sale | 9,086 | 25.85 | 234,873 | D |
11 Mar 2024 21:50 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 07 Mar 2024 | Sale | 2,434 | 25.85 | 62,919 | D |
11 Mar 2024 21:52 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 07 Mar 2024 | Sale | 1,557 | 26.2 | 40,793 | D |
11 Mar 2024 21:52 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 07 Mar 2024 | Sale | 8,364 | 25.8 | 215,791 | D |
11 Mar 2024 21:45 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 07 Mar 2024 | Sale | 2,273 | 25.85 | 58,757 | D |
05 Mar 2024 17:07 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE OPPORTUNITY FUND I, L.P. | 10% | 01 Mar 2024 | Sale | 17,099 | 30.05 | 513,825 | I |
05 Mar 2024 17:07 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE OPPORTUNITY FUND I, L.P. | 10% | 01 Mar 2024 | Sale | 29,435 | 30.05 | 884,522 | D |
05 Mar 2024 17:08 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 01 Mar 2024 | Sale | 17,099 | 30.05 | 513,825 | I |
05 Mar 2024 17:08 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 01 Mar 2024 | Sale | 29,435 | 30.05 | 884,522 | I |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 01 Mar 2024 | Sale | 564 | 28.65 | 16,159 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 01 Mar 2024 | Sale | 8,747 | 28.22 | 246,840 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 01 Mar 2024 | Sale | 1,442 | 29.7 | 42,827 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | SCALZO RICHARD WILLIAM | SVP, Head of Finance & Admin. | 29 Feb 2024 | Sale | 3,429 | 27.5 | 94,298 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 01 Mar 2024 | Sale | 8,715 | 29.06 | 253,258 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 01 Mar 2024 | Sale | 14,103 | 28.25 | 398,410 | D |
01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 29 Feb 2024 | Sale | 4,268 | 27.5 | 117,370 | D |
01 Mar 2024 21:38 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 01 Mar 2024 | Sale | 1,414 | 29.7 | 41,996 | D |
01 Mar 2024 21:38 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 01 Mar 2024 | Sale | 74,090 | 29.23 | 2,165,651 | D |
01 Mar 2024 21:38 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 01 Mar 2024 | Sale | 18,976 | 28.25 | 536,072 | D |
01 Mar 2024 21:38 | DYN | Dyne Therapeutics Inc | BRUMM JOSHUA T | CEO & President | 29 Feb 2024 | Sale | 5,520 | 27.5 | 151,800 | D |
28 Feb 2024 17:06 | DYN | Dyne Therapeutics Inc | FARWELL WILDON | Chief Medical Officer | 28 Feb 2024 | Sale | 407 | 25 | 10,175 | D |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 210 | 25.25 | 5,302 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 360 | 25.25 | 9,090 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 13,109 | 24.83 | 325,496 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 22,567 | 24.83 | 560,339 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 2,430 | 25.25 | 61,358 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 28 Feb 2024 | Sale | 152,244 | 24.83 | 3,780,219 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 2,216 | 24.68 | 54,691 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 3,821 | 24.68 | 94,302 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 23,505 | 24.38 | 573,052 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 40,455 | 24.38 | 986,293 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 25,779 | 24.68 | 636,226 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 27 Feb 2024 | Sale | 272,923 | 24.38 | 6,653,863 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 5,580 | 23.98 | 133,808 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 9,603 | 23.98 | 230,280 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 11,736 | 23.59 | 276,852 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 20,205 | 23.59 | 476,636 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 64,783 | 23.98 | 1,553,496 | I |
28 Feb 2024 19:15 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 26 Feb 2024 | Sale | 136,312 | 23.59 | 3,215,600 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 210 | 25.25 | 5,302 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 13,109 | 24.83 | 325,496 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 360 | 25.25 | 9,090 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 22,567 | 24.83 | 560,339 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 2,430 | 25.25 | 61,358 | D |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 28 Feb 2024 | Sale | 152,244 | 24.83 | 3,780,219 | D |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 23,505 | 24.38 | 573,052 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 2,216 | 24.68 | 54,691 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 3,821 | 24.68 | 94,302 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 40,455 | 24.38 | 986,293 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 25,779 | 24.68 | 636,226 | D |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 27 Feb 2024 | Sale | 272,923 | 24.38 | 6,653,863 | D |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 5,580 | 23.98 | 133,808 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 11,736 | 23.59 | 276,852 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 9,603 | 23.98 | 230,280 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 20,205 | 23.59 | 476,636 | I |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 136,312 | 23.59 | 3,215,600 | D |
28 Feb 2024 19:13 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 26 Feb 2024 | Sale | 64,783 | 23.98 | 1,553,496 | D |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 23 Feb 2024 | Sale | 23,648 | 22.7 | 536,810 | I |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 23 Feb 2024 | Sale | 13,738 | 22.7 | 311,853 | I |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 23 Feb 2024 | Sale | 159,542 | 22.7 | 3,621,603 | I |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 22 Feb 2024 | Sale | 119,360 | 22.66 | 2,704,698 | I |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 21 Feb 2024 | Sale | 35,164 | 23.14 | 813,695 | I |
23 Feb 2024 18:59 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 21 Feb 2024 | Sale | 149,337 | 22.44 | 3,351,122 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 23 Feb 2024 | Sale | 13,738 | 22.7 | 311,853 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 23 Feb 2024 | Sale | 23,648 | 22.7 | 536,810 | I |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 23 Feb 2024 | Sale | 159,542 | 22.7 | 3,621,603 | D |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 21 Feb 2024 | Sale | 35,164 | 23.14 | 813,695 | D |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 22 Feb 2024 | Sale | 119,360 | 22.66 | 2,704,698 | D |
23 Feb 2024 18:58 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 21 Feb 2024 | Sale | 149,337 | 22.44 | 3,351,122 | D |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 20 Feb 2024 | Sale | 3,510 | 23.4 | 82,134 | D |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 20 Feb 2024 | Sale | 166,029 | 22.71 | 3,770,519 | D |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 16 Feb 2024 | Sale | 162,707 | 23.14 | 3,765,040 | D |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 15 Feb 2024 | Sale | 2,113 | 24.45 | 51,663 | D |
20 Feb 2024 18:35 | DYN | Dyne Therapeutics Inc | ATLAS VENTURE FUND XI, L.P. | 10% | 15 Feb 2024 | Sale | 175,793 | 23.88 | 4,197,937 | D |
20 Feb 2024 18:36 | DYN | Dyne Therapeutics Inc | RHODES JASON P | Director | 20 Feb 2024 | Sale | 3,510 | 23.4 | 82,134 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)